Abstract
Melanin is the dominant skin pigment, and the intensity of pigmentation is a conspicuous component of distinction between racially different human populations. Humans evolved in sub tropical Africa and constitutive pigmentation was likely dark to protect from damage by intense sun exposure, a persistent feature of highly melanized skin.1,2 When descendants of these early humans moved north, dark skinned people were at a disadvantage for vitamin D (ViD) conversion and thus paler skinned descendants had a selective advantage in moderate climates and far northern latitudes. At the same time, the loss of dark pigment made these fair skinned people more prone to acute and chronic adverse effects of sun exposure, such as sunburn and skin cancer.3 This chapter discusses the endogenous protection that epidermal pigment provides to humans. The sole source of cutaneous melanin are melanocytes that reside in the epidermis. They provide the surrounding keratinocytes with melanosomes, specialized organelles that contain melanins. Darkness and hue of constitutive pigmentation are not due to different densities of melanocytes but rather caused by differences in size and distribution of melanosomes, the overall melanin content of the epidermis and the relative amounts of eumelanin and pheomelanin. Although there is no doubt that melanin is protective from environmental ultraviolet (UV) exposure, the mechanisms by which this happens are not completely clarified. In addition to constitutive differences, multiple exogenous and endogenous agents modulate melanin pigmentation. This chapter will focus primarily on those changes that are induced by UV radiation (UVR). However, as will become evident, this approach does not lead to exclusion but rather to the inclusion of other factors that regulate epidermal melanization.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Harris EE, Meyer D. The molecular signature of selection underlying human adaptations. Am J Phys Anthropol. 2006;Suppl 43:89–130.
Lao O, de Gruijwwter JM, van Duijn K, Navarro A, Kayser M. Signatures of positive selection in genes associated with human skin pigmentation as revealed from analyses of single nucleotide polymorphisms. Ann Hum Genet. 2007;71:354–369.
Briollais L, Chompret A, Guilloud-Bataille M, Bressac-de Paillerets B, Avril MF, Demenais F. Patterns of familial aggregation of three melanoma risk factors: great number of naevi, light phototype and high degree of sun exposure. Int J Epidemiol. 2000;29:408–415.
Westerhof W. The discovery of the human melanocyte. Pigment Cell Res. 2006;19:183–193.
Passeron T, Mantoux F, Ortonne JP. Genetic disorders of pigmentation. Clin Dermatol. 2005;23:56–67.
Raposo G, Marks MS. Melanosomes–dark organelles enlighten endosomal membrane transport. Nat Rev Mol Cell Biol. 2007;8:786–797.
Bennett DC, Lamoreux ML. The color loci of mice–a genetic century. Pigment Cell Res. 2003;16:333–344.
Steingrimsson E, Copeland NG, Jenkins NA. Mouse coat color mutations: from fancy mice to functional genomics. Dev Dyn. 2006;235:2401–2411.
Holbrook KA, Underwood RA, Vogel AM, Gown AM, Kimball H. The appearance, density and distribution of melanocytes in human embryonic and fetal skin revealed by the anti-melanoma monoclonal antibody, HMB-45. Anat Embryol (Berl). 1989;180:443–455.
Lang D, Brown CB, Epstein JA. Neural crest formation and craniofacial development. In: Epstein C, Erickson R, Wynshaw-Boris A, eds. Molecular Basis of Inborn Errors of Development. San Francisco, CA: Oxford University Press; 2004:67–74.
Bondurand N, Pingault V, Goerich DE, et al. Interaction among SOX10, PAX3 and MITF, three genes altered in Waardenburg syndrome. Hum Mol Genet. 2000;9:1907–1917.
Hornyak TJ, Hayes DJ, Chiu LY, Ziff EB. Transcription factors in melanocyte development: distinct roles for Pax-3 and Mitf. Mech Dev. 2001;101:47–59.
Potterf SB, Furumura M, Dunn KJ, Arnheiter H, Pavan WJ. Transcription factor hierarchy in Waardenburg syndrome: regulation of MITF expression by SOX10 and PAX3. Hum Genet. 2000;107:1–6.
Widlund HR, Fisher DE. Microphthalmia-associated transcription factor: a critical regulator of pigment cell development and survival. Oncogene. 2003;22:3035–3041.
Tassabehji M, Newton VE, Read AP. Waardenburg syndrome type 2 caused by mutations in the human microphthalmia (MITF) gene. Nat Genet. 1994;8:251–255.
Wehrle-Haller B. The role of Kit-ligand in melanocyte development and epidermal homeostasis. Pigment Cell Res. 2003;16:287–296.
Toki F, Suzuki N, Inoue K, et al. Intestinal aganglionosis associated with the Waardenburg syndrome: report of two cases and review of the literature. Pediatr Surg Int. 2003;19:725–728.
Tomita Y, Suzuki T. Genetics of pigmentary disorders. Am J Med Genet C Semin Med Genet. 2004;131C:75–81.
Nordlund JJ. The melanocyte and the epidermal melanin unit: an expanded concept. Dermatol Clin. 2007;25:271–281,vii.
Marks MS, Seabra MC. The melanosome: membrane dynamics in black and white. Nat Rev Mol Cell Biol. 2001;2:738–748.
Slominski A, Tobin DJ, Shibahara S, Wortsman J. Melanin pigmentation in mammalian skin and its hormonal regulation. Physiol Rev. 2004;84:1155–1228.
Kushimoto T, Basrur V, Valencia J, et al. A model for melanosome biogenesis based on the purification and analysis of early melanosomes. Proc Natl Acad Sci U S A. 2001;98:10698–10703.
Alaluf S, Heath A, Carter N, et al. Variation in melanin content and composition in type V and VI photoexposed and photoprotected human skin: the dominant role of DHI. Pigment Cell Res. 2001;14:337–347.
Theos AC, Truschel ST, Raposo G, Marks MS. The Silver locus product Pmel17/gp100/Silv/ME20: controversial in name and in function. Pigment Cell Res. 2005;18:322–336.
Wei ML. Hermansky-Pudlak syndrome: a disease of protein trafficking and organelle function. Pigment Cell Res. 2006;19:19–42.
Kaplan J, De Domenico I, Ward DM. Chediak-Higashi syndrome. Curr Opin Hematol. 2008;15:22–29.
Ito S. The IFPCS presidential lecture: a chemist’s view of melanogenesis. Pigment Cell Res. 2003;16:230–236.
del Marmol V, Beermann F. Tyrosinase and related proteins in mammalian pigmentation. FEBS Lett. 1996;381:165–168.
Smit N, Tilgmann C, Karhunen T, et al. O-methylation of L-DOPA in melanin metabolism and the presence of catechol-O-methyltransferase in melanocytes. Pigment Cell Res. 1994;7:403–408.
Lee ZH, Hou L, Moellmann G, et al. Characterization and subcellular localization of human Pmel 17/silver, a 110-kDa (pre)melanosomal membrane protein associated with 5,6,Â-dihydroxyindole-2-carboxylic acid (DHICA) converting activity. J Invest Dermatol. 1996;106:605–610.
Schallreuter KU, Kothari S, Chavan B, Spencer JD. Regulation of melanogenesis–controversies and new concepts. Exp Dermatol. 2008;17:395–404.
Ito S. Reexamination of the structure of eumelanin. Biochim Biophys Acta. 1986;883:155–161.
Zajac GW, Gallas JM, Cheng J, Eisner M, Moss SC, Alvarado-Swaisgood AE. The fundamental unit of synthetic melanin: a verification by tunneling microscopy of X-ray scattering results. Biochim Biophys Acta. 1994;1199:271–278.
Clancy CM, Simon JD. Ultrastructural organization of eumelanin from Sepia officinalis measured by atomic force microscopy. Biochemistry. 2001;40:13353–13360.
Meng S, Kaxiras E. Theoretical models of eumelanin protomolecules and their optical properties. Biophys J. 2008;94:2095–2105.
Alaluf S, Atkins D, Barrett K, Blount M, Carter N, Heath A. Ethnic variation in melanin content and composition in photoexposed and photoprotected human skin. Pigment Cell Res. 2002;15:112–118.
del Marmol V, Ito S, Bouchard B, et al. Cysteine deprivation promotes eumelanogenesis in human melanoma cells. J Invest Dermatol. 1996;107:698–702.
Okulicz JF, Shah RS, Schwartz RA, Janniger CK. Oculocutaneous albinism. J Eur Acad Dermatol Venereol. 2003;17:251–256.
Menasche G, Ho CH, Sanal O, et al. Griscelli syndrome restricted to hypopigmentation results from a melanophilin defect (GS3) or a MYO5A F-exon deletion (GS1). J Clin Invest. 2003;112:450–456.
Corbeel L, Freson K. Rab proteins and Rab-associated proteins: major actors in the mechanism of protein-trafficking disorders. Eur J Pediatr. 2008;167:723–729.
Wolff K, Konrad K. Phagocytosis of latex beads by epidermal keratinocytes in vivo. J Ultrastruct Res. 1972;39:262–280.
Cardinali G, Ceccarelli S, Kovacs D, et al. Keratinocyte growth factor promotes melanosome transfer to keratinocytes. J Invest Dermatol. 2005;125:1190–1199.
Boissy RE. Melanosome transfer to and translocation in the keratinocyte. Exp Dermatol. 2003;12(Suppl 2):5–12.
Sharlow ER, Paine CS, Babiarz L, Eisinger M, Shapiro S, Seiberg M. The protease-2 upregulates keratinocyte phagocytosis. J Cell Sci. 2000;113(Pt 17):3093–3101.
Virador VM, Muller J, Wu X, et al. Influence of alpha-melanocyte-stimulating hormone and ultraviolet radiation on the transfer of melanosomes to keratinocytes. Faseb J. 2002;16:105–107.
Wolff K. Melanocyte-keratinocyte interactions in vivo: the fate of melanosomes. Yale J Biol Med. 1973;46:384–396.
Otaki N, Seiji M. Degradation of melanosomes by lysosomes. J Invest Dermatol. 1971;57:1–5.
Hori Y, Toda K, Pathak MA, Clark WHJr., Fitzpatrick TB. A fine-structure study of the human epidermal melanosome complex and its acid phosphatase activity. J Ultrastruct Res. 1968;25:109–120.
Borovansky J, Elleder M. Melanosome degradation: fact or fiction. Pigment Cell Res. 2003;16:280–286.
Honigsmann H. Erythema and pigmentation. Photodermatol Photoimmunol Photomed. 2002;18:75–81.
Cripps DJ. Natural and artificial photoprotection. J Invest Dermatol. 1981;77:154–157.
Westerhof W, Estevez-Uscanga O, Meens J, Kammeyer A, Durocq M, Cario I. The relation between constitutional skin color and photosensitivity estimated from UV-induced erythema and pigmentation dose-response curves. J Invest Dermatol. 1990;94:812–816.
Andreassi L, Simoni S, Fiorini P, Fimiani M. Phenotypic characters related to skin type and minimal erythemal dose. Photodermatol. 1987;4:43–46.
Gange RW, Blackett AD, Matzinger EA, Sutherland BM, Kochevar IE. Comparative protection efficiency of UVA- and UVB-induced tans against erythema and formation of endonuclease-sensitive sites in DNA by UVB in human skin. J Invest Dermatol. 1985;85:362–364.
Sheehan JM, Potten CS, Young AR. Tanning in human skin types II and III offers modest photoprotection against erythema. Photochem Photobiol. 1998;68:588–592.
Barnetson RS, Ooi TK, Zhuang L, et al. [Nle4-D-Phe7]-alpha-melanocyte-stimulating hormone significantly increased pigmentation and decreased UV damage in fair-skinned Caucasian volunteers. J Invest Dermatol. 2006;126:1869–1878.
D’Orazio JA, Nobuhisa T, Cui R, et al. Topical drug rescue strategy and skin protection based on the role of Mc1r in UV-induced tanning. Nature. 2006;443:340–344.
Yamaguchi Y, Takahashi K, Zmudzka BZ, et al. Human skin responses to UV radiation: pigment in the upper epidermis protects against DNA damage in the lower epidermis and facilitates apoptosis. Faseb J. 2006;20:1486–1488.
Takeuchi S, Zhang W, Wakamatsu K, et al. Melanin acts as a potent UVB photosensi-tizer to cause an atypical mode of cell death in murine skin. Proc Natl Acad Sci U S A. 2004;101:15076–15081.
Munyao TM, Othieno-Abinya NA. Cutaneous basal cell carcinoma in Kenya. East Afr Med J. 1999;76:97–100.
Kollias N, Sayre RM, Zeise L, Chedekel MR. Photoprotection by melanin. J Photochem Photobiol B. 1991;9:135–160.
Kromberg JG, Castle D, Zwane EM, Jenkins T. Albinism and skin cancer in Southern Africa. Clin Genet. 1989;36:43–52.
Staples MP, Elwood M, Burton RC, Williams JL, Marks R, Giles GG. Non-melanoma skin cancer in Australia: the 2002 national survey and trends since 1985. Med J Aust. 2006;184:6–10.
Cunningham J, Rumbold AR, Zhang X, Condon JR. Incidence, aetiology, and outcomes of cancer in Indigenous peoples in Australia. Lancet Oncol. 2008;9:585–595.
Condon JR, Armstrong BK, Barnes T, Zhao Y. Cancer incidence and survival for indigenous Australians in the Northern Territory. Aust N Z J Public Health. 2005;29:123–128.
Wlaschek M, Tantcheva-Poor I, Naderi L, et al. Solar UV irradiation and dermal photoaging. J Photochem Photobiol B. 2001;63:41–51.
Holick MF. The cutaneous photosynthesis of previtamin D3: a unique photoendocrine system. J Invest Dermatol. 1981;77:51–58.
Giovannucci E, Liu Y, Hollis BW, Rimm EB. 25-Hydroxyvitamin D and risk of myocardial infarction in men: a prospective study. Arch Intern Med. 2008;168:1174–1180.
Giovannucci E, Liu Y, Rimm EB, et al. Prospective study of predictors of vitamin D status and cancer incidence and mortality in men. J Natl Cancer Inst. 2006;98:451–459.
Young AR. Chromophores in human skin. Phys Med Biol. 1997;42:789–802.
Riesz J, Gilmore J, Meredith P. Quantitative scattering of melanin solutions. Biophys J. 2006;90:4137–4144.
Meredith P, Sarna T. The physical and chemical properties of eumelanin. Pigment Cell Res. 2006;19:572–594.
Riesz J, Sarna T, Meredith P. Radiative relaxation in synthetic pheomelanin. J Phys Chem B. 2006;110:13985–13990.
Rajadhyaksha M, Grossman M, Esterowitz D, Webb RH, Anderson RR. In vivo confocal scanning laser microscopy of human skin: melanin provides strong contrast. J Invest Dermatol. 1995;104:946–952.
Rajadhyaksha M, Anderson RR, Webb RH. Video-rate confocal scanning laser microscope for imaging human tissues in vivo. Appl Opt. 1999;38:2105–2115.
Rajadhyaksha M, Gonzalez S, Zavislan JM, Anderson RR, Webb RH. In vivo confocal scanning laser microscopy of human skin II: advances in instrumentation and comparison with histology. J Invest Dermatol. 1999;113:293–303.
Yamashita T, Akita H, Astner S, Miyakawa M, Lerner EA, Gonzalez S. In vivo assessment of pigmentary and vascular compartments changes in UVA exposed skin by reflectance-mode confocal microscopy. Exp Dermatol. 2007;16:905–911.
Riley PA. Radicals in melanin biochemistry. Ann N Y Acad Sci. 1988;551:111–119; discussion 119-120.
Rozanowska M, Sarna T, Land EJ, Truscott TG. Free radical scavenging properties of melanin interaction of eu- and pheo-melanin models with reducing and oxidising radicals. Free Radic Biol Med. 1999;26:518–525.
Poh Agin P, Sayre RM, Chedekel MR. Photodegradation of phaeomelanin: an in vitro model. Photochem Photobiol. 1980;31:359–362.
Lerner AB, McGuire JS. Melanocyte-stimulating hormone and adrenocorticotrophic hormone. their relation to pigmentation. N Engl J Med. 1964;270:539–546.
Abdel-Malek Z, Swope VB, Suzuki I, et al. Mitogenic and melanogenic stimulation of normal human melanocytes by melanotropic peptides. Proc Natl Acad Sci U S A. 1995;92:1789–1793.
Garcia-Borron JC, Sanchez-Laorden BL, Jimenez-Cervantes, C. Melanocortin-1 receptor structure and functional regulation. Pigment Cell Res. 2005;18:393–410.
Konig S, Luger TA, Scholzen TE. Monitoring neuropeptide-specific proteases: processing of the proopiomelanocortin peptides adrenocorticotropin and alpha-melanocyte-stimulating hormone in the skin. Exp Dermatol. 2006;15:751–761.
Hunt G, Kyne S, Wakamatsu K, Ito S, Thody AJ. Nle4DPhe7 alpha-melanocyte-stimulating hormone increases the eumelanin:phaeomelanin ratio in cultured human melanocytes. J Invest Dermatol. 1995;104:83–85.
Gaggioli C, Busca R, Abbe P, Ortonne JP, Ballotti R. Microphthalmia-associated transcription factor (MITF) is required but is not sufficient to induce the expression of melanogenic genes. Pigment Cell Res. 2003;16:374–382.
Yasumoto K, Yokoyama K, Takahashi K, Tomita Y, Shibahara S. Functional analysis of microphthalmia-associated transcription factor in pigment cell-specific transcription of the human tyrosinase family genes. J Biol Chem. 1997;272:503–509.
Aoki H, Moro O. Involvement of microphthalmia-associated transcription factor (MITF) in expression of human melanocortin-1 receptor (MC1R). Life Sci. 2002;71:2171–2179.
Scott MC, Suzuki I, Abdel-Malek ZA. Regulation of the human melanocortin 1 receptor expression in epidermal melanocytes by paracrine and endocrine factors and by ultraviolet radiation. Pigment Cell Res. 2002;15:433–439.
Suzuki I, Tada A, Ollmann MM, et al. Agouti signaling protein inhibits melanogenesis and the response of human melanocytes to alpha-melanotropin. J Invest Dermatol. 1997;108:838–842.
Abdel-Malek Z, Suzuki I, Tada A, Im S, Akcali C. The melanocortin-1 receptor and human pigmentation. Ann N Y Acad Sci. 1999;885:117–133.
Hirobe T. Role of keratinocyte-derived factors involved in regulating the proliferation and differentiation of mammalian epidermal melanocytes. Pigment Cell Res. 2005;18:2–12.
Kadekaro AL, Kavanagh RJ, Wakamatsu K, Ito S, Pipitone MA, Abdel-Malek ZA. Cutaneous photobiology. The melanocyte vs. the sun: who will win the final round? Pigment Cell Res. 2003;16:434–447.
Robbins LS, Nadeau JH, Johnson KR, et al. Pigmentation phenotypes of variant extension locus alleles result from point mutations that alter MSH receptor function. Cell. 1993;72:827–834.
Bastiaens M, ter Huurne J, Gruis N, et al. The melanocortin-1-receptor gene is the major freckle gene. Hum Mol Genet. 2001;10:1701–1708.
Ringholm A, Klovins J, Rudzish R, Phillips S, Rees JL, Schioth HB. Pharmacological characterization of loss of function mutations of the human melanocortin 1 receptor that are associated with red hair. J Invest Dermatol. 2004;123:917–923.
Kennedy C, ter Huurne J, Berkhout M, et al. Melanocortin 1 receptor (MC1R) gene variants are associated with an increased risk for cutaneous melanoma which is largely independent of skin type and hair color. J Invest Dermatol. 2001;117:294–300.
Smith G, Wilkie MJ, Deeni YY, et al. Melanocortin 1 receptor (MC1R) genotype influences erythemal sensitivity to psoralen-ultraviolet A photochemotherapy. Br J Dermatol. 2007;157:1230–1234.
Parrish JA, Jaenicke KF, Anderson RR. Erythema and melanogenesis action spectra of normal human skin. Photochem Photobiol. 1982;36:187–191.
Wagner JK, Parra EJ, L Norton H, Jovel C, Shriver MD. Skin responses to ultraviolet radiation: effects of constitutive pigmentation, sex, and ancestry. Pigment Cell Res. 2002;15:385–390.
Chung JH, Koh WS, Youn JI. Relevance of skin phototyping to a Korean population. Clin Exp Dermatol. 1994;19:476–478.
Stanford DG, Georgouras KE, Sullivan EA, Greenoak GE. Skin phototyping in Asian Australians. Australas J Dermatol. 1996;37(Suppl 1):S36–S38.
Zmudzka BZ, Hearing VJ, Beer JZ. Photobiologic role of melanin distribution in the epidermis. J Photochem Photobiol B. 2006;84:231.
Hacham H, Freeman SE, Gange RW, Maytum DJ, Sutherland JC, Sutherland BM. Do pyrimidine dimer yields correlate with erythema induction in human skin irradiated in situ with ultraviolet light (275-365 nm)? Photochem Photobiol. 1991;53:559–563.
de Gruijl FR, Rebel H. Early events in UV carcinogenesis–DNA damage, target cells and mutant p53 foci. Photochem Photobiol. 2008;84:382–387.
Eller MS, Ostrom K, Gilchrest BA. DNA damage enhances melanogenesis. Proc Natl Acad Sci U S A. 1996;93:1087–1092.
Gilchrest BA, Zhai S, Eller MS, Yarosh DB, Yaar M. Treatment of human melanocytes and S91 melanoma cells with the DNA repair enzyme T4 endonuclease V enhances melanogenesis after ultraviolet irradiation. J Invest Dermatol. 1993;101:666–672.
Nylander K, Bourdon JC, Bray SE, et al. Transcriptional activation of tyrosinase and TRP-1 by p53 links UV irradiation to the protective tanning response. J Pathol. 2000;190:39–46.
Khlgatian MK, Hadshiew IM, Asawanonda P, et al. Tyrosinase gene expression is regulated by p53. J Invest Dermatol. 2002;118:126–132.
Cui R, Widlund HR, Feige E, et al. Central role of p53 in the suntan response and pathologic hyperpigmentation. Cell. 2007;128:853–864.
Bohm M, Wolff I, Scholzen TE, et al. alpha-Melanocyte-stimulating hormone protects from ultraviolet radiation-induced apoptosis and DNA damage. J Biol Chem. 2005;280:5795–5802.
Kadekaro AL, Kavanagh R, Kanto H, et al. alpha-Melanocortin and endothelin-1 activate antiapoptotic pathways and reduce DNA damage in human melanocytes. Cancer Res. 2005;65:4292–4299.
Passeron T, Namiki T, Passeron HJ, Le Pape E, Hearing VJ. Forskolin protects keratinocytes from UVB-induced apoptosis and increases DNA repair independent of its effects on melanogenesis. J Invest Dermatol. 2009;129:162–166.
Scott G, Deng A, Rodriguez-Burford C, et al. Protease-activated receptor 2, a receptor involved in melanosome transfer, is upregulated in human skin by ultraviolet irradiation. J Invest Dermatol. 2001;117:1412–1420.
Marchese C, Maresca V, Cardinali G, et al. UVB-induced activation and internalization of keratinocyte growth factor receptor. Oncogene. 2003;22:2422–2431.
Gilchrest BA, Blog FB, Szabo G. Effects of aging and chronic sun exposure on melanocytes in human skin. J Invest Dermatol. 1979;73:141–143.
Herzberg AJ, Dinehart SM. Chronologic aging in black skin. Am J Dermatopathol. 1989;11:319–328.
Staricco RJ, Pinkus H. Quantitative and qualitative data on the pigment cells of adult human epidermis. J Invest Dermatol. 1957;28:33–45.
Alaluf S, Barrett K, Blount M, Carter N. Ethnic variation in tyrosinase and TYRP1 expression in photoexposed and photoprotected human skin. Pigment Cell Res. 2003;16:35–42.
Tadokoro T, Yamaguchi Y, Batzer J, et al. Mechanisms of skin tanning in different racial/ethnic groups in response to ultraviolet radiation. J Invest Dermatol. 2005;124:1326–1332.
Abdel-Malek Z, Swope V, Collins C, Boissy R, Zhao H, Nordlund J. Contribution of melanogenic proteins to the heterogeneous pigmentation of human melanocytes. J Cell Sci. 1993;106 (Pt 4):1323–1331.
Andreassi L, Casini L, Simoni S, Bartalini P, Fimiani M. Measurement of cutaneous colour and assessment of skin type. Photodermatol Photoimmunol Photomed. 1990;7:20–24.
Pershing LK, Tirumala VP, Nelson JL, et al. Reflectance spectrophotometer: the dermatologists’ sphygmomanometer for skin phototyping? J Invest Dermatol. 2008;128:1633–1640.
Konrad K, Wolff K. Hyperpigmentation, melanosome size, and distribution patterns of melanosomes. Arch Dermatol. 1973;107:853–860.
Szabo G, Gerald AB, Pathak MA, Fitzpatrick TB. Racial differences in the fate of melanosomes in human epidermis. Nature. 1969;222:1081–1082.
Limat A, Salomon D, Carraux P, Saurat JH, Hunziker T. Human melanocytes grown in epidermal equivalents transfer their melanin to follicular outer root sheath keratinocytes. Arch Dermatol Res. 1999;291:325–332.
Cardinali G, Bolasco G, Aspite N, et al. Melanosome transfer promoted by keratinocyte growth factor in light and dark skin-derived keratinocytes. J Invest Dermatol. 2008;128:558–567.
Seiberg M, Paine C, Sharlow E, et al. The protease-activated receptor 2 regulates pigmentation via keratinocyte-melanocyte interactions. Exp Cell Res. 2000;254:25–32.
Babiarz-Magee L, Chen N, Seiberg M, Lin CB. The expression and activation of protease-activated receptor-2 correlate with skin color. Pigment Cell Res. 2004;17:241–251.
Yoshida Y, Hachiya A, Sriwiriyanont P, et al. Functional analysis of keratinocytes in skin color using a human skin substitute model composed of cells derived from different skin pigmentation types. Faseb J. 2007;21:2829–2839.
Sarangarajan R, Zhao Y, Babcock G, Cornelius J, Lamoreux ML, Boissy RE. Mutant alleles at the brown locus encoding tyrosinase-related protein-1 (TRP-1) affect proliferation of mouse melanocytes in culture. Pigment Cell Res. 2000;13:337–344.
Han J, Kraft P, Nan H, et al. A genome-wide association study identifies novel alleles associated with hair color and skin pigmentation. PLoS Genet. 2008;4, e1000074.
Norton HL, Kittles RA, Parra E, et al. Genetic evidence for the convergent evolution of light skin in Europeans and East Asians. Mol Biol Evol. 2007;24:710–722.
Kobayashi N, Nakagawa A, Muramatsu T, et al. Supranuclear melanin caps reduce ultraviolet induced DNA photoproducts in human epidermis. J Invest Dermatol. 1998;110:806–810.
Acknowledgment
Financial support was provided by a grant from the Dermatology Foundation (PI: Christopher R. Shea, MD). We thank Diana Bolotin, MD, PhD for critical review of the manuscript.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2009 Springer-Verlag London Limited
About this chapter
Cite this chapter
Ortel, B., Racz, M., Lang, D., Calzavara-Pinton, P.G. (2009). Endogenous Protection by Melanin. In: Baron, E. (eds) Light-Based Therapies for Skin of Color. Springer, London. https://doi.org/10.1007/978-1-84882-328-0_3
Download citation
DOI: https://doi.org/10.1007/978-1-84882-328-0_3
Published:
Publisher Name: Springer, London
Print ISBN: 978-1-84882-327-3
Online ISBN: 978-1-84882-328-0
eBook Packages: MedicineMedicine (R0)